Published

Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2026-01-01
Source: PubMed
DOI: 10.1177/02698811241287542
PubMed: 39480198

Authors

Aghajanian S Shafiee A Parvizi Omran S Rezaei Nejad A Jafarabady K Kohandel Gargari O Rajai S Mohammadi I Bahrami Babaheidari T Bakhtiyari M

Watch author

Derived topics and classifications

psilocybin Depression Clinical Trial Meta-Analysis Systematic Review Review Article Meta-Analysis

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06

Related papers

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27 Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disordersPsychedelics. · 2025-06-10 Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatmentPsychedelics. · 2025-10-14 Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?Psychedelics. · 2025-09-02 An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United StatesPsychedelics. · 2024-09-13 Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depressionPsychedelics. · 2024-08-12 Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01